Global methylation status of LINE-1 in pediatric myelodysplastic syndrome: a predictive biomarker of prognosis?

Leuk Lymphoma. 2022 Dec;63(14):3484-3487. doi: 10.1080/10428194.2022.2115842. Epub 2022 Sep 7.

Authors

Viviane Lamim Lovatel¹, Eliane Ferreira Rodrigues¹, Beatriz Ferreira da Silva¹, Cecilia de Souza Fernandez², Elaine Sobral da Costa³, Eliana Abdelhay¹, Sheila Coelho Soares Lima⁴, Teresa de Souza Fernandez¹

Affiliations

¹ Cytogenetic Laboratory, Bone Marrow Transplantation Center (CEMO), National Cancer Institute (INCA), Rio de Janeiro, Brazil.
² Mathematical and Statistical Institute of Federal Fluminense University (UFF), Niterói, Brazil.
³ Pediatrics Department, Faculty of Medicine, Federal University of Rio de Janeiro, Rio de Janeiro, Brazil.
⁴ Molecular Carcinogenesis Program, National Cancer Institute (INCA), Rio de Janeiro, Brazil.

PMID: 36070601
DOI: 10.1080/10428194.2022.2115842

No abstract available

MeSH terms

Biomarkers
Child
DNA Methylation
Humans
Methylation
Myelodysplastic Syndromes* / genetics
Prognosis

Substances

Biomarkers